RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (pinkbeige vertical) A G
RM
+
Illustration of tirzepatide (silver helix) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured helices across membrane)
RM
+
Antidiabetic drug tirzepatide molecular structure illustration
RM
+
Antidiabetic drug tirzepatide molecular structure illustration
RM
+
Illustration showing the molecular structure of tirzepatide a drug used to treat type 2 diabetes and obesity It functions by mimicking glucose-depen
RM
+
Illustration showing the molecular structure of tirzepatide a drug used to treat type 2 diabetes and obesity It functions by mimicking glucose-depen
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (beige vertical) A G prot
RM
+
Illustration of tirzepatide (silver helix) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured helices across membrane)
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3d structur
ED
+
Januvia diabetes drug molecular model Januvia (sitagliptin) is a hypoglycaemic drug one that reduces blood sugar levels Diabetes is a condition in
RM
+
Illustration of tirzepatide (silver helix) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured helices across membrane)
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (beige vertical structure)
RF
+
GLP-1 receptors and semaglutide agonists illustration
RF
+
GLP-1 receptors and semaglutide agonists illustration
RF
+
Inactivated GLP-1 receptor near semaglutide illustration
RF
+
GLP-1 receptor activated by semaglutide illustration
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Liraglutide diabetes and obesity drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles with thick blac
RF
+
Liraglutide diabetes and obesity drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Liraglutide diabetes and obesity drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by th
RF
+
Liraglutide diabetes and obesity drug molecule illustration
RF
+
Exenatide diabetes drug molecule illustration
RF
+
Exenatide diabetes drug molecule Stylized skeletal formula (chemical structure) Atoms are shown as color-coded circles connected by thin bonds on a
RF
+
Exenatide diabetes drug molecule White skeletal formula on dark teal gradient background with hexagonal pattern
RF
+
Exenatide diabetes drug molecule Blue skeletal formula on white background
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 molecule
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
RF
+
Glucagon-like peptide 1 (GLP1 7-36) molecule GLP-1 analogues are used in the treatment of diabetes and include exenatide liraglutide lixisenatide
30
0
https://www.afloimages.com/search/glucagon%20like%20peptide.html